Global Molecular Quality Controls Market Size To Worth USD 367.24 Million By 2032 | CAGR of 6.5%

In This Article:

SPHERICAL INSIGHTS LLP
SPHERICAL INSIGHTS LLP

The Molecular Quality Controls Market was valued at USD 195.64 Million in 2022. The Global molecular quality controls market is expected to reach USD 367.24 Million by 2032, According to a research report published by Spherical Insights & Consulting. Companies Covered: F. Hoffmann-La Roche Ltd., Danaher Corporation, Bio-Rad Laboratories, Inc., Anchor Molecular, Thermo Fisher Scientific, Inc., Randox Laboratories Ltd., LGC Limited, Abbott Laboratories, Fortress Diagnostics, SERO AS, Anchor Molecular, Vircell S.L., Ortho Clinical Diagnostics, Inc., Sun Diagnostics, LLC, and Others.

New York, United States , Dec. 01, 2023 (GLOBE NEWSWIRE) -- The Global Molecular Quality Controls Market size is to grow from USD 195.64 Million in 2022 to USD 367.24 Million by 2032, at a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period.

Get a Sample PDF Brochure: https://www.sphericalinsights.com/request-sample/2620

Molecular Quality Controls (MQCs) play a pivotal role in ensuring the accuracy, reliability, and consistency of molecular diagnostic assays and laboratory testing processes. These controls consist of well-defined samples with known target sequences, concentrations, or mutations, which are integrated into testing workflows alongside patient samples. By mimicking real patient specimens, MQCs enable continuous monitoring of assay performance, identifying potential variations, instrument issues, or procedural errors. This proactive approach enhances the validity of test results, minimizes false positives/negatives, and aids in troubleshooting.

Browse key industry insights spread across 200 pages with 160 market data tables and figures & charts from the report on the "Global Molecular Quality Controls Market Size, Share, and COVID-19 Impact Analysis, By Product (Independent Controls and Instrument-Specific Controls), By Analyte Type (Single-Analyte Controls and Multi-Analyte Controls), By Application (Infectious Disease Diagnostics, Oncology Testing, Genetic Testing, and Others), By End-User (Diagnostic Laboratories, Hospitals, IVD Manufacturers & Contract Research Organizations, Academic & Research Institutes, and Others), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2022 – 2032

Buy Now Full Report https://www.sphericalinsights.com/checkout/2620

In 2022, the independent controls segment accounted for around 38.2% market share

On the basis of the product, the global molecular quality controls market is segmented into independent controls and instrument-specific controls. The independent controls segment has emerged as the dominant force in the molecular quality controls (MQCs) market. This dominance can be attributed to the segment's versatility in catering to various molecular diagnostic assays across different platforms and instruments. Independent controls offer the flexibility to assess assay performance independently from commercial test kits, making them a preferred choice for laboratories aiming to customize their quality control processes.